Lack Of Details On J&J COVID Vaccine Trial Safety Pause Raises ACIP Concerns About Transparency

 
• By Sue Sutter
  
White transparent skeleton leaf with beautiful texture on a turquoise abstract background on glass with shiny water dew drops
ACIP pushed Janssen to be more transparent about the safety event that led to a vaccine trial enrollment pause. • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Vaccines

More from Pink Sheet